Month: April 2020

Experts have created widely publicized models showing the potential death toll of COVID-19, but these fail to account for additional impacts on health and wealth.
As Nicholas Vardy explains today, public policy based on these models has ignored necessary trade-offs.

Editor’s Note: In the time of COVID-19, it’s more important than ever for investors to manage their risk. That’s what Nicholas Vardy is discussing in his latest video, “How to Manage Financial Risks During Pandemic.” Be sure to give it a watch and follow Nicholas’ Facebook page so you never miss an update!

– Christina Grieves, Senior Managing Editor

It seems that everyone in …read more […]

Clinical data on potential treatments for the new coronavirus could help sustain a market bounce that has buoyed stocks after last month’s plunge, as investors look for signs that authorities may be able to stabilize the pandemic. Highly anticipated data for a Gilead Sciences Inc experimental antiviral drug are expected later this month. Analysts are also awaiting results in the near-term for products already approved for other conditions from companies such as Roche Holding and Regeneron Pharmaceuticals. …read more […]

‘It would be unusual and unprecedented for a bear market or recession to only last 30 or 45 days. It just doesn’t happen,’ said Darrell Cronk, president of the Wells Fargo Investment Institute. …read more […]

Molson Coors (NYSE: TAP) dividend yield has climbed with the recent market drop. Since the start of the year, it’s climbed from below 3% to over 5%. Now that we’ve likely entered a recession, many companies will see a decrease in sales. Although, alcohol stocks tend to do relatively well during a downturn.
Molson falls under the Consumer Staple Stocks category. If you’d like to, you can open that link to see 20 other stocks with reliable dividends. And today, we’re going to look at TAP dividend history. But first, let’s look at the company overview.
Molson Coors Business Overview
Molson Coors is …read more […]

It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that… …read more […]

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […] …read more […]

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […] …read more […]

Coronavirus is probably the 1 concern in investors’ minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted that a US recession is imminent and US stocks will go down by at least 20% in the next 3-6 […] …read more […]